We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for hemin (Recordati Rare Diseases Australia Pty Ltd)
Active ingredients
hemin
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
Indicated for the treatment of acute attacks of hepatic porphyria (acute intermittent porphyria, porphyria variegate, hereditary corproporphyria and delta-aminolevulinic acid dehydratase porphyria)
Therapeutic area
Haematology